University of California San Francisco

Publications

  1. Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
    2022 | PubMed
  2. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients.
    2019 | PubMed
  3. Thalidomide treatment prevents chronic graft rejection after aortic transplantation in rats - an experimental study.
    2017 | PubMed
  4. miR-21 promotes fibrosis in an acute cardiac allograft transplantation model.
    2016 | PubMed
  5. Immunobiology of fibrin-based engineered heart tissue.
    2015 | PubMed
  6. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.
    2013 | PubMed
  7. Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.
    2011 | PubMed
  8. Non-volume-loaded heart provides a more relevant heterotopic transplantation model.
    2010 | PubMed
  9. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart.
    2009 | PubMed
  10. Failed induction of heme oxygenase 1 in endothelial cells exposed to the hemoglobin based oxygen carrier Oxyglobin.
    2008 | PubMed
  11. The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity.
    2006 | PubMed
  12. Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model.
    2003 | PubMed
  13. Hypoimmune FK binding protein 12-knockout CD19 CAR T cells achieve deep tissue B-cell depletion and control Nalm6 tumors in immunosuppressed humanized mice.
    2025 | PubMed
  14. Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity.
    2023 | PubMed
  15. The SIRPα-CD47 immune checkpoint in NK cells.
    2021 | PubMed
  16. No effect of thymosin beta-4 on the expression of the transcription factor Islet-1 in the adult murine heart.
    2018 | PubMed
  17. Vein Interposition Model: A Suitable Model to Study Bypass Graft Patency.
    2017 | PubMed
  18. Distal Airway Stem Cells are Essential for Lung Regeneration.
    2015 | PubMed
  19. SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts.
    2014 | PubMed
  20. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    2012 | PubMed
  21. Bioluminescence imaging for assessment of immune responses following implantation of engineered heart tissue (EHT).
    2011 | PubMed
  22. LAD-ligation: a murine model of myocardial infarction.
    2009 | PubMed
  23. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.
    2008 | PubMed
  24. Coincidence of aortic valve stenosis and regurgitation and multiple cardiac papillary fibroelastomas in a young male adult.
    2007 | PubMed
  25. The phytoestrogen biochaninA weakens acute cardiac allograft rejection without affecting the reproductive system.
    2005 | PubMed
  26. Myoblasts survive intracardiac transfer and divide further after transplantation.
    2002 | PubMed
  27. Progress and challenges in developing allogeneic cell therapies.
    2025 | PubMed
  28. Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice.
    2023 | PubMed
  29. A Cryoinjury Model to Study Myocardial Infarction in the Mouse.
    2019 | PubMed
  30. Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta.
    2018 | PubMed
  31. The Selective JAK1/3-Inhibitor R507 Mitigates Obliterative Airway Disease Both With Systemic Administration and Aerosol Inhalation.
    2016 | PubMed
  32. Effective Apical Infection of Differentiated Human Bronchial Epithelial Cells and Induction of Proinflammatory Chemokines by the Highly Pneumotropic Human Adenovirus Type 14p1.
    2015 | PubMed
  33. Dichloroacetate prevents restenosis in preclinical animal models of vessel injury.
    2014 | PubMed
  34. Localization of Islet-1-positive cells in the healthy and infarcted adult murine heart.
    2012 | PubMed
  35. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.
    2010 | PubMed
  36. Imaging in-stent restenosis: an inexpensive, reliable, and rapid preclinical model.
    2009 | PubMed
  37. Introducing the first polymer-free leflunomide eluting stent.
    2008 | PubMed
  38. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    2007 | PubMed
  39. FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studies.
    2004 | PubMed
  40. Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease.
    2025 | PubMed
  41. Clinical Improvement With Transcatheter Edge-to-Edge Tricuspid Repair Irrespective of Right Atrial Pressure.
    2024 | PubMed
  42. Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathy.
    2024 | PubMed
  43. Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice.
    2021 | PubMed
  44. Dead space ventilation promotes alveolar hypocapnia reducing surfactant secretion by altering mitochondrial function.
    2019 | PubMed
  45. Differences in Vascular Response between Balloon Overstretch and Stent Overexpansion in Nonatherosclerotic Porcine Coronary Arteries.
    2017 | PubMed
  46. Sex Differences in Immunology: More Severe Development of Experimental Pulmonary Hypertension in Male Rats Exposed to Vascular Endothelial Growth Factor Receptor Blockade.
    2015 | PubMed
  47. Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.
    2015 | PubMed
  48. Small animal models of experimental obliterative bronchiolitis.
    2013 | PubMed
  49. Assessment of physiologic natural killer cell cytotoxicity in vitro.
    2011 | PubMed
  50. Heterotopic and orthotopic tracheal transplantation in mice used as models to study the development of obliterative airway disease.
    2010 | PubMed
  51. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation.
    2008 | PubMed
  52. Right atrial mass after primary repair of an atrial septal defect: thrombus masquerading as a myxoma.
    2007 | PubMed
  53. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.
    2006 | PubMed
  54. Successful resection of a symptomatic right ventricular lipoma.
    2003 | PubMed
  55. Hypoimmune CD19 CAR T cells treat allogeneic mice with features of spontaneous systemic lupus erythematosus.
    2025 | PubMed
  56. Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques.
    2023 | PubMed
  57. Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact.
    2020 | PubMed
  58. Sphingosine-1-phosphate receptor 1 regulates neointimal growth in a humanized model for restenosis.
    2018 | PubMed
  59. Orthotopic tracheal transplantation using human bronchus: an original xenotransplant model of obliterative airway disorder.
    2016 | PubMed
  60. Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.
    2015 | PubMed
  61. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.
    2014 | PubMed
  62. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    2012 | PubMed
  63. Prevention of transplant coronary artery disease by prenylation inhibitors.
    2011 | PubMed
  64. Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium.
    2009 | PubMed
  65. Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection.
    2008 | PubMed
  66. Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells.
    2007 | PubMed
  67. FK778 and tacrolimus prevent the development of obliterative airway disease after heterotopic rat tracheal transplantation.
    2005 | PubMed
  68. Wildlife ecologist: aldo leopoid.
    1988 | PubMed
  69. Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series.
    2024 | PubMed
  70. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.
    2023 | PubMed
  71. De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans.
    2019 | PubMed
  72. Opportunities for Lung Repair and Regeneration: An Overview.
    2017 | PubMed
  73. "Bioengineered lungs" Best science paper in JHLT 2014-2015.
    2016 | PubMed
  74. Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties.
    2015 | PubMed
  75. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
    2013 | PubMed
  76. Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.
    2011 | PubMed
  77. Sustained inhibition of epsilon protein kinase C inhibits vascular restenosis after balloon injury and stenting.
    2010 | PubMed
  78. A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection.
    2009 | PubMed
  79. Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins.
    2008 | PubMed
  80. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    2006 | PubMed
  81. The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent.
    2004 | PubMed
  82. Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression.
    2025 | PubMed
  83. Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate.
    2024 | PubMed
  84. Immunomodulation Therapy Using Tolerogenic Macrophages in a Rodent Model of Pulmonary Hypertension.
    2021 | PubMed
  85. Exosomal profiling in cardiac allograft rejection: Best basic science article in 2018.
    2018 | PubMed
  86. The ubiquitin-proteasome system: A potential therapeutic target for heart failure.
    2017 | PubMed
  87. Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats.
    2015 | PubMed
  88. Erratum: miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development.
    2015 | PubMed
  89. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    2013 | PubMed
  90. Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
    2011 | PubMed
  91. Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation.
    2009 | PubMed
  92. Comparison of different adult stem cell types for treatment of myocardial ischemia.
    2008 | PubMed
  93. Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?
    2007 | PubMed
  94. Sirolimus and FK778: a comparison of two anti-proliferative immunosuppressants for prevention of experimental obliterative airway disease.
    2006 | PubMed
  95. New technique for chest opening in mice: U-sternotomy.
    2003 | PubMed
  96. Inhibition of polymorphonuclear cells averts cytotoxicity against hypoimmune cells in xenotransplantation.
    2025 | PubMed
  97. Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice.
    2023 | PubMed
  98. The H-Y Antigen in Embryonic Stem Cells Causes Rejection in Syngeneic Female Recipients.
    2020 | PubMed
  99. Optimization of oxygenation during ex vivo lung perfusion-Best basic science article in 2017.
    2018 | PubMed
  100. miR-126: a potential new key player in hypoxia and reperfusion?
    2016 | PubMed
  101. Advancing knowledge of right ventricular pathophysiology in chronic pressure overload: Insights from experimental studies.
    2015 | PubMed
  102. Inducing myointimal hyperplasia versus atherosclerosis in mice: an introduction of two valid models.
    2014 | PubMed
  103. Human internal mammary artery (IMA) transplantation and stenting: a human model to study the development of in-stent restenosis.
    2012 | PubMed
  104. Orthotopic aortic transplantation: a rat model to study the development of chronic vasculopathy.
    2010 | PubMed
  105. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    2009 | PubMed
  106. Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.
    2008 | PubMed
  107. Experimental orthotopic tracheal transplantation: The Stanford technique.
    2007 | PubMed
  108. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
    2005 | PubMed
  109. Allogeneic Beta Cells with No Immunosuppression. Reply.
    2025 | PubMed
  110. The HIP mouse and all of its organs are completely invisible to allogeneic immune cells.
    2024 | PubMed